IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Xeris Biopharma Holdings

CUSIP: 98422EAB9 | TRACE | 5 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

Capstone Investment Advisors, LLC23,074,000
0.1% of portfolio›$62.6M
Polar Asset Management Partners Inc.10,500,000
0.5% of portfolio›$28.8M
StyleTurnoverLocationFiled
Capstone Investment Advisors, LLC
23,074,000$62.6M0.1%GrowthVery HighNew York, NY2026-08-17
Polar Asset Management Partners Inc.
10,500,000$28.8M0.5%ValueVery HighToronto, Australia2026-08-14